Harnessing CRISPR-Cas9 for Genome Editing in Streptococcus pneumoniae D39V.

Bacterial Proteins / genetics CRISPR-Associated Protein 9 CRISPR-Cas Systems Gene Editing / methods Genome, Bacterial Streptococcus pneumoniae / genetics Virulence Factors / genetics
CRISPR Cas9 Streptococcus pneumoniae genome editing plasmids

Journal

Applied and environmental microbiology
ISSN: 1098-5336
Titre abrégé: Appl Environ Microbiol
Pays: United States
ID NLM: 7605801

Informations de publication

Date de publication:
26 02 2021
Historique:
received: 10 11 2020
accepted: 21 12 2020
pubmed: 6 1 2021
medline: 7 4 2021
entrez: 5 1 2021
Statut: epublish

Résumé

CRISPR-Cas systems provide bacteria and archaea with adaptive immunity against viruses and plasmids by the detection and cleavage of invading foreign DNA. Modified versions of this system can be exploited as a biotechnological tool for precise genome editing at a targeted locus. Here, we developed a replicative plasmid that carries the CRISPR-Cas9 system for RNA-programmable genome editing by counterselection in the opportunistic human pathogen

Identifiants

DOI: 10.1128/AEM.02762-20 PMID: 33397704 PMC: PMC8105017
pubmed: 33397704
pii: AEM.02762-20
doi: 10.1128/AEM.02762-20
pmc: PMC8105017
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Virulence Factors 0
CRISPR-Associated Protein 9 EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 Synefiaridou and Veening.

Références

Mol Microbiol. 2002 Mar;43(6):1565-75
pubmed: 11952905
Nucleic Acids Res. 2014;42(17):e131
pubmed: 25074379
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
PLoS One. 2014 Jun 24;9(6):e100510
pubmed: 24959661
PLoS One. 2014 Feb 18;9(2):e89427
pubmed: 24558498
Appl Environ Microbiol. 2001 Nov;67(11):5190-6
pubmed: 11679344
ACS Synth Biol. 2015 Jun 19;4(6):723-8
pubmed: 25458909
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27608-27619
pubmed: 33087560
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5959-E5968
pubmed: 28674002
Mol Microbiol. 1995 Jan;15(2):367-79
pubmed: 7538190
Appl Environ Microbiol. 2007 Mar;73(5):1514-24
pubmed: 17261526
Microb Cell Fact. 2019 Jan 31;18(1):22
pubmed: 30704485
Mol Microbiol. 2020 Jan;113(1):297-308
pubmed: 31693257
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
FEMS Microbiol Lett. 2019 Nov 1;366(22):
pubmed: 31905238
Plasmid. 1986 Sep;16(2):135-60
pubmed: 3749334
ACS Synth Biol. 2015 Mar 20;4(3):228-39
pubmed: 24845455
Nat Rev Microbiol. 2008 Apr;6(4):288-301
pubmed: 18340341
J Bacteriol. 1992 Sep;174(17):5633-8
pubmed: 1324906
Nat Biotechnol. 2013 Mar;31(3):233-9
pubmed: 23360965
Appl Environ Microbiol. 2016 Aug 15;82(17):5421-7
pubmed: 27342565
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Appl Environ Microbiol. 1998 Dec;64(12):4796-802
pubmed: 9835564
Nucleic Acids Res. 2018 Nov 2;46(19):9971-9989
pubmed: 30107613
Lancet. 2009 Sep 12;374(9693):893-902
pubmed: 19748398
Cell Host Microbe. 2021 Jan 13;29(1):107-120.e6
pubmed: 33120116
J Hyg (Lond). 1928 Jan;27(2):113-59
pubmed: 20474956
Elife. 2020 Sep 23;9:
pubmed: 32965219
Trends Microbiol. 2015 Apr;23(4):225-32
pubmed: 25698413
Appl Environ Microbiol. 1982 Jun;43(6):1272-7
pubmed: 16346027
J Bacteriol. 1996 Feb;178(3):931-5
pubmed: 8550537
Science. 2007 Mar 23;315(5819):1709-12
pubmed: 17379808
Environ Microbiol. 2013 Dec;15(12):3133-57
pubmed: 23848140
Mol Syst Biol. 2017 May 10;13(5):931
pubmed: 28490437
Mol Microbiol. 2009 Oct;74(2):395-408
pubmed: 19737355
Nat Microbiol. 2016 Jun 20;1(7):16077
pubmed: 27572972
Nat Rev Microbiol. 2007 Nov;5(11):852-61
pubmed: 17938628
Appl Environ Microbiol. 2015 Apr;81(7):2506-14
pubmed: 25636838
mBio. 2018 Oct 2;9(5):
pubmed: 30279289
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2100-5
pubmed: 11854505
Nat Commun. 2018 May 15;9(1):1911
pubmed: 29765029
Expert Rev Vaccines. 2012 Jul;11(7):841-55
pubmed: 22913260
Appl Environ Microbiol. 2019 Oct 16;85(21):
pubmed: 31444197
FEMS Microbiol Lett. 2007 Mar;268(2):217-24
pubmed: 17328748
J Exp Med. 1944 Feb 1;79(2):137-58
pubmed: 19871359
Genome Res. 2004 Jul;14(7):1394-403
pubmed: 15231754
ACS Synth Biol. 2019 Jun 21;8(6):1379-1390
pubmed: 31181894
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Genes (Basel). 2019 May 22;10(5):
pubmed: 31121970
Nat Rev Microbiol. 2014 Mar;12(3):181-96
pubmed: 24509783
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278

Auteurs

Dimitra Synefiaridou (D)

Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Jan-Willem Veening (JW)

Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland Jan-Willem.Veening@unil.ch.
ORCID: 0000-0002-3162-6634

Articles similaires

Atomic view of photosynthetic metabolite permeability pathways and confinement in synthetic carboxysome shells.

Daipayan Sarkar, Christopher Maffeo, Markus Sutter et al.
1.00
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria

Comparative genomic analysis and characterization of novel high-quality draft genomes from the coal metagenome.

Arunmozhi Bharathi Achudhan, Lilly M Saleena
1.00
Coal Metagenome Phylogeny Bacteria Genome, Bacterial

Menthol as an effective inhibitor of quorum sensing and biofilm formation in Candida albicans and Candida glabrata by targeting the transcriptional repressor TUP1.

Pouria Khodavandi, Maryam Miri Soogh, Fahimeh Alizadeh et al.
1.00
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Generation of isogenic models of Angelman syndrome and Prader-Willi syndrome in CRISPR/Cas9-engineered human embryonic stem cells.

Rachel B Gilmore, Dea Gorka, Christopher E Stoddard et al.
1.00
Prader-Willi Syndrome Humans Angelman Syndrome CRISPR-Cas Systems Human Embryonic Stem Cells

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Harnessing CRISPR-Cas9 for Genome Editing in...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines associées aux CRISPR › Protéine-9 associée à CRISPR › Harnessing CRISPR-Cas9 for Genome Editing in...
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Épigenèse génétique › Extinction de l'expression des gènes › Systèmes CRISPR-Cas › Harnessing CRISPR-Cas9 for Genome Editing in...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Génie génétique › Édition de gène › Harnessing CRISPR-Cas9 for Genome Editing in...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Génome microbien › Génome bactérien › Harnessing CRISPR-Cas9 for Genome Editing in...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Streptococcaceae › Streptococcus › Streptococcus pneumoniae › Harnessing CRISPR-Cas9 for Genome Editing in...
questionsmedicales.fr › Facteurs biologiques › Toxines biologiques › Facteurs de virulence › Harnessing CRISPR-Cas9 for Genome Editing in...